BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yin F, Han X, Yao SK, Wang XL, Yang HC. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. World J Gastroenterol 2016; 22(9): 2837-2843 [PMID: 26973422 DOI: 10.3748/wjg.v22.i9.2837]
URL: https://www.wjgnet.com/1007-9327/full/v22/i9/2837.htm
Number Citing Articles
1
Xin Nie, Ergang Guo, Cheng Wu, Dongbo Liu, Wei Sun, Linli Zhang, Guoxian Long, Qi Mei, Kongming Wu, Huihua Xiong, Guoqing Hu. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathwayCancer Medicine 2019; 8(4): 1779 doi: 10.1002/cam4.2056
2
Hong-Kun Wu, Chang Liu, Xiao-Xia Fan, Hao Wang, Lin Zhou. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancerCancer Biomarkers 2017; 20(2): 191 doi: 10.3233/CBM-170204
3
Yuriko Takayama-Isagawa, Kengo Kanetaka, Shinichiro Kobayashi, Akira Yoneda, Shinichiro Ito, Susumu Eguchi. High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasisScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54394-1
4
Christopher Welberry, Isabel Macdonald, Jane McElveen, Celine Parsy-Kowalska, Jared Allen, Graham Healey, William Irving, Andrea Murray, Caroline Chapman, Vasilis Kosmoliaptsis. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinomaPLOS ONE 2020; 15(5): e0232247 doi: 10.1371/journal.pone.0232247
5
Chaoran Zang, Yan Zhao, Ling Qin, Guihai Liu, Jianping Sun, Kang Li, Yanan Zhao, Shoupeng Sheng, Honghai Zhang, Ning He, Peng Zhao, Qi Wang, Xi Li, Yanchun Peng, Tao Dong, Yonghong Zhang. Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stagesBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08720-9
6
Shiva Moein, Daniel G. Tenen, Giovanni Amabile, Li Chai. SALL4: An Intriguing Therapeutic Target in Cancer TreatmentCells 2022; 11(16): 2601 doi: 10.3390/cells11162601
7
Fatma A. Abouelnazar, Xiaoxin Zhang, Maoye Wang, Jiahui Zhang, Dan Yu, Xueyan Zang, Jiayin Zhang, Yixin Li, Jing Xu, Qiurong Yang, Yue Zhou, Haozhou Tang, Yanzheng Wang, Jianmei Gu, Xu Zhang. The new advance of SALL4 in cancer: Function, regulation, and implicationJournal of Clinical Laboratory Analysis 2023; 37(9-10) doi: 10.1002/jcla.24927
8
William Cruz, Huang Huang, Brian Barber, Elisa Pasini, Lili Ding, Gang Zheng, Juan Chen, Mamatha Bhat. Lipoprotein‐Like Nanoparticle Carrying Small Interfering RNA Against Spalt‐Like Transcription Factor 4 Effectively Targets Hepatocellular Carcinoma Cells and Decreases Tumor BurdenHepatology Communications 2020; 4(5): 769 doi: 10.1002/hep4.1493
9
Xiaorong Deng, Weiwei Wei, Niangen Huang, Yumeng Shi, Mingwen Huang, Yehong Yan, Dongjian Li, Jilin Yi, Xinbao Wang. Tumor repressor gene chondroadherin oppose migration and proliferation in hepatocellular carcinoma and predicts a good survivalOncotarget 2017; 8(36): 60270 doi: 10.18632/oncotarget.19811
10
Xinglong Wu, Lianjun Di, Chengfang Li, Suyuan Zhang, Na Tan, Jiajia Huang, Biguang Tuo. Early hepatoid adenocarcinoma of the stomach with signet ring cell carcinoma: A case report and clinicopathological featuresFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1016447
11
Jun Liu, Madeline A. Sauer, Shaza G. Hussein, Junyu Yang, Daniel G. Tenen, Li Chai. SALL4 and microRNA: The Role of Let-7Genes 2021; 12(9): 1301 doi: 10.3390/genes12091301
12
Jun Liu, Kevin Park, Ziyang Shen, Hannah Lee, Purnima Geetha, Mohammadreza Pakyari, Li Chai. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1285370
13
Shinichi Tsuruta, Yoshihiro Ohishi, Minako Fujiwara, Eikichi Ihara, Yoshihiro Ogawa, Eiji Oki, Masafumi Nakamura, Yoshinao Oda. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do existHuman Pathology 2019; 88: 27 doi: 10.1016/j.humpath.2019.03.006
14
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancerWorld Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
15
Lei Li, Guangjie Liao. Clinicopathological progress of dual-phenotype hepatocellular carcinomaAnnals of Oncology Research and Therapy 2023; 3(1): 6 doi: 10.4103/aort.aort_32_22
16
H Fan, Z Cui, H Zhang, S K Mani, A Diab, L Lefrancois, N Fares, P Merle, O Andrisani. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infectionOncogene 2017; 36(17): 2435 doi: 10.1038/onc.2016.399
17
Lorenzo Nicolè, Tiziana Sanavia, Nicola Veronese, Rocco Cappellesso, Claudio Luchini, Paolo Dabrilli, Ambrogio Fassina. Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysisOncotarget 2017; 8(14): 22968 doi: 10.18632/oncotarget.14952
18
Mei Chen, Lu Li, Peng‐Sheng Zheng. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β‐catenin pathway via CTNNB1Cancer Science 2019; 110(9): 2794 doi: 10.1111/cas.14140
19
Chuanjin Liu, Haibin Wu, Yanyan Li, Liang Shen, Renchun Yu, Hongwei Yin, Ting Sun, Chunming Sun, Youxin Zhou, Ziwei Du. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathwayJournal of Neuro-Oncology 2017; 135(2): 263 doi: 10.1007/s11060-017-2589-3
20
Yakun Wang, Li Sun, Zhongwu Li, Jing Gao, Sai Ge, Cheng Zhang, Jiajia Yuan, Xicheng Wang, Jian Li, Zhihao Lu, Jifang Gong, Ming Lu, Jun Zhou, Zhi Peng, Lin Shen, Xiaotian Zhang. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular featuresGastric Cancer 2019; 22(6): 1183 doi: 10.1007/s10120-019-00965-5
21
Izabela Zarębska, Arkadiusz Gzil, Justyna Durślewicz, Damian Jaworski, Paulina Antosik, Navid Ahmadi, Marta Smolińska-Świtała, Dariusz Grzanka, Łukasz Szylberg. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markersClinics and Research in Hepatology and Gastroenterology 2021; 45(3): 101664 doi: 10.1016/j.clinre.2021.101664
22
Aqsa Nazir, Muhammad Aqib, Muhammad Usman. Liver Cancer - Genesis, Progression and Metastasis2023;  doi: 10.5772/intechopen.106020
23
Claudia Álvarez, Aracelly Quiroz, Diego Benítez-Riquelme, Elizabeth Riffo, Ariel F. Castro, Roxana Pincheira. SALL Proteins; Common and Antagonistic Roles in CancerCancers 2021; 13(24): 6292 doi: 10.3390/cancers13246292
24
Feng Xue, Chunchao Shi, Lixue Yang, Chenqi Li, Yang Liu, Yanfu Sun, Ruiliang Ge. WITHDRAWN: Prognostic biomarker AASS suppresses proliferation, migration and predicts a good survival of hepatocellular carcinoma in vivo and in vitroLife Sciences 2019;  doi: 10.1016/j.lfs.2019.05.080